Clinical applications of precision oncology require accurate tests that can distinguish cancerspecific mutations from errors introduced at each step of next generation sequencing (NGS). For NGS to successfully improve patient lives, discriminating between true mutations and artifacts is crucial. To date, no study has addressed the effects of cross site reproducibility together with the potentially influential interactions between biological, technical, and computational factors on the accurate identification of variants.
actionable practices for cancer mutation detection experiments and analysis using NGS technologies.
Introduction
Precision oncology seeks to identify whether a patient carries specific genetic aberrations relevant to a treatment or disease in order to guide pharmaceutical target identification, inform patient therapy, dictate dosing, suggest probability of adverse events 1 , and/or determine membership of an individual into a specific patient subset. With ever-decreasing cost, more researchers and clinicians are using next-generation sequencing (NGS) to profile clinical samples. Currently, a panoply of sample processing protocols, library preparation methods, sequencing technologies, and bioinformatics pipelines exists to detect mutations relevant to cancer. Furthermore, samples can arrive at the testing lab in different states (fresh vs FFPE), the amount of input DNA can be variable, and tumor purity is rarely consistent across clinical samples, presenting significant challenges to sequencing assays, instruments, and analytical tools. All of these technical challenges likely underlie the estimated irreproducibility rates of 51%-89% in pre-clinical research [2] [3] [4] .
Previous studies have successfully addressed individual components of somatic variant calling in isolation; for example, bioinformatics pipelines 5, 6 or sample factors 7 have been studied individually. Many reports have compared bioinformatics pipelines/callers based on the accuracy and consistency of mutation detection [8] [9] [10] ; others have compared other components, such as assay development 11 , library preparation 12 , and biosample resources 13, 14 . The majority of these studies used either in-silico approaches with simulated ground truth or real tumor samples 11, [15] [16] [17] for benchmarking. The data sets or samples from previous studies either do not accurately represent real human tumor biopsies (in-silico) or are not sustainable (real tumor) for multiple benchmark studies. Although benchmarking with tumor tissue sounds more realistic for cancer mutation detection, the existence of spatial heterogenicity of tumor tissue 18, 19 , i.e. different slices of tissue may have different mutation profiles, and the limited sample quantity cannot support comprehensive studies required for reliable assessment of detection reproducibility.
Here we develop systematic methods to evaluate performance using realistic reference samples and datasets. We profile the previously characterized [20] [21] [22] and commercially available cell lines (breast cancer and matched normal). We outlined an experimental design where we sought to test the influence of each variable within a typical NGS-based tumor profiling workflow. Our design included different biospecimen types (fresh vs FFPE), input amounts, library preparation methods, different Illumina sequencing instruments, sequencing centers, and bioinformatics pipelines, which allowed us to investigate how these experimental and analytical elements may interact to affect mutation detection. We find that the whole process of cancer mutation detection, from experiment to informatics, greatly benefits from a wellintegrated protocol. While reproducibility of WGS is better than WES, artifacts could be raised from biospecimen source, laboratory protocols, or bioinformatics tools.
Results

Study design
To pinpoint factors affecting somatic variant calling, a matched pair of breast cancer cell lines (HCC1395 and HCC1395BL) was selected for profiling (detailed in our "reference samples" manuscript, DOI:10.1101/625624). Although practical constraints precluded an exhaustive examination of all possible combinations of all possible variables, those chosen for study here reflect our real-world assessment of commonly-encountered factors exerting significant effects on the final result ( Fig. 1a, Suppl. Fig. 1 ).
Our experimental design covered many real-world scenarios that occur in research or clinical laboratories, such as FFPE, heterogeneity of tumor biopsy, limited specimen DNA, everchanging NGS machine models, and analytical tools. We generated 1,015 call sets to evaluate the cross-center and cross-platform reproducibility of mutation detection, as well as the performance of mutation calling under various conditions.
Survey of read quality
WGS was performed at six sequencing centers, generating a total of 42 sequencing results from the standard TruSeq PCR-free libraries prepared from 1000 ng of input DNA. The cross-platform comparison included three different platforms: HiSeq4000, HiSeq X10, and NovaSeq S6000. All sequencing centers and platforms produced high quality data as demonstrated by base call Phred quality scores above Q30, and greater than 99.8% of reads mapped to the reference genome (GRCh38). Variation was observed in the quantity of reads per sample generated, with some centers consistently delivering much higher coverages (100X) than others (50X), which was driven by sequencing platform yield differences as well as run pooling schemes and target coverage ( Fig. 1b) . Among the WGS libraries prepared using fresh cells, insert size distribution and G/C content were uniform (40 -43% G/C). Moreover, all of the WGS libraries had very low adapter contamination (<0.5%). Less than 10% of reads mapped redundantly for most libraries, indicating high complexity of the WGS libraries. Similar mapping statistics were observed in NovaSeq WGS runs (Suppl . Table 1) .
Similarly, WES performed across six sequencing centers using three different HiSeq models (HiSeq1500, HiSeq2500, and HiSeq4000), generated sequencing results where 99% of reads were mapped successfully (Suppl. Table 2 ). The largest variations in sequencing yield and coverage on target were seen between sequencing centers and even sometimes between different replicates of the same cell line at the same sequencing center. These variations were largely due to uneven library pooling and sequencing yield differences between platforms. This confounding factor was easily identified by statistical analysis and could be removed with downsampling to produce equivalent coverage for each run. WES libraries, demonstrated much higher adapter contamination among all six centers, compared with WGS data. More than 20% of sequences in WES from two sequencing centers came from adapters, while the remaining centers had less than 12% adapter contamination (Suppl. Fig. 2a ). Higher adapter contamination was related to longer sequencing read length in base pairs (bp, 2x 150 bp vs. 2x125 bp). The WES libraries had higher G/C content (44 -54%) compared with WGS libraries (40 -43%). The libraries with more serious adapter contamination also had much higher G/C content compared other WES libraries. Generally, regions with more reads on target region had higher G/C content (Suppl. Fig. 2b) .
When comparing library preparation kits across different DNA inputs, both similarities and differences were noted. The average percentage of mapped reads ranged from 96% to 99.9% across TruSeq PCR-free, TruSeq-Nano, and Nextera Flex libraries prepared with 250, 100, 10, or 1 ng of DNA input. However, the percentage of non-redundant reads was very low (<20%) for TruSeq-Nano with 1 ng input, presumably due to PCR amplification (Suppl. Fig. 2c ).
Nevertheless, the percentage of non-redundant reads for 1 ng with Nextera Flex (also a PCRbased protocol) was reasonably good (~70%; comparable to the performance of the TruSeq-Nano 100 ng protocol). In addition, overall G/C content was not affected by DNA input amount or library preparation kit. Thus, the Nextera Flex Library prep may be superior to the TruSeq-Nano for lower input DNA amounts. The FFPE libraries were prepared from cells fixed with formaldehyde at four time intervals. These samples yielded results with a high percentage of mapped reads and non-redundant read frequencies that were comparable to the results generated from WGS libraries prepared with fresh cells (Suppl. Table 1 ).
Evaluation of DNA quality
The Global Imbalance Value (GIV) is a commonly used indicator of DNA damage 23 and was thus used to monitor DNA quality in NGS runs. We found high GIV scores for the G>T/C>A mutation pair in WES of HCC1395 and HCC1395BL cell lines. The GIV for G>T/C>A scores was inversely correlated with insert fragment size (Suppl. Table 3 ), which is also found to be associated with DNA shearing time. Longer shearing time produces shorter DNA fragments. Insert fragment size and G/C content were also inversely correlated, suggesting increased off-target (non-exome region) reads when larger DNA fragments were sequenced. We observed high G>T/C>A scores (>1.5) when insert fragment sizes were between 160-180 bp. When insert fragment sizes were larger than 200 bp, we observed little or no imbalance ( Fig. 1c) . In contrast, we did not observe this imbalance in WGS runs (Suppl. Fig. 2d ), for which the insert sizes were normally larger than 300 bp (Suppl. Table 1 , Suppl. Fig. 3a ). We did not observe such imbalance in other mutation pairs, such as T>G/A>C ( Fig. 1c) . Previous reports demonstrate that excessive acoustic shearing results in 8-oxoG damage 24 . Therefore, the high ratio of G>T/C>A observed in some WES runs was likely an artifact of oxidative DNA damage during the fragmentation process.
Formaldehyde also causes the deamination of guanine. Thus, the GIV of G>T/C>A is a good indicator of FFPE induced DNA damage 25 . Consistent with this, we observed "dose" dependent GIV imbalance in FFPE sample WGS runs ( Fig. 1d) . Taken together, these results indicate that WES is more sensitive to site-to-site library preparation variation than WGS. We propose that WGS rather than WES is best suitable to FFPE.
Reproducibility of cancer mutation detection
To assess the reproducibility of cancer mutation detection with WES and WGS, we performed a total of twelve repeats of WES and WGS at six sequencing centers ( Fig. 1a, Suppl. Fig. 1 ). We used three mutation callers (MuTect2 26 , Strelka2 27 , and SomaticSniper 28 ) on alignments from three aligners (Bowtie2 29 , BWA 30 , and NovoAlign) to generate a total of 108 Variant Call Format (VCF) files from WES and WGS analyses separately.
In this study, as shown in Fig. 2a , both BWA and NovoAlign demonstrated a substantial pool of calls which were agreed upon under every repeated WGS or WES run called by three callers (MuTect2, Strelka2, and SomaticSniper). We did not observe significant differences among results from the three aligners on WES. However, calling results from WGS with Bowtie2 as the aligner tended to have fewer consistent SNV calls, indicating that mutation calling from Bowtie2 alignment was conservative ( Fig. 2a ).
We then fixed the alignment to the widely used Burrows-Wheeler Aligner (BWA), and compared the results from our three callers, observing the differences in WES versus WGS run performance. While SomaticSniper displayed results that showed more consistent SNV calls in WES than in WGS, those derived by MuTect2 and Strelka2 showed greater divergence. Both MuTect2 and Strelka2 were more consistent when used for WGS rather than WES ( Fig. 2b) .
Further examination of Strelka2 results from BWA alignments of twelve repeated WES and WGS runs confirmed this observation ( Fig. 2c) . Here we also introduced the O_Score, a metric to measure reproducibility of repeated analyses (see Supplemental Methods). O_Scores for Strelka2 and MuTect2 for WES runs were not only significantly lower than for WGS runs, but also more variable. Unexpectedly, even though its overall O_Score was much lower than Strelka2 and MuTect2 in WGS runs, SomaticSniper showed better consistency in calling results in WES than in WGS (Suppl. Fig. 4a ). We also compared WGS runs with HiSeq vs. WGS runs with NovaSeq using BWA for alignment and Strelka2 for calling. Both platforms were remarkably similar in terms of reproducibility, indicating that results from HiSeq and NovaSeq were comparable (Suppl. Fig. 4b ). Taken together, Strelka2 had the best reproducibility in WGS repeated runs but the worst in WES repeated runs, whereas MuTect2 had the best reproducibility in WES repeated runs.
Factors influencing reproducibility of cancer mutation detection
After establishing the O_Score to measure the reproducibility of NGS platform mutation detection, we also used it to determine what variables contribute most to variation between different repeated WGS or WES analyses separately. We included not only callers but machine model, read coverage, non-duplicated reads, G/C content, insert size, and two GIV scores (G>T/C>A and T>G/A>C). The combination of these parameters represented most of the variation in WGS and WES runs, as a very high proportion of variance in the O_Score could be predicted by these variables. For WGS, the combination of these eight individual variables accounted for >99% of the O_Score variance (R 2 > 0.99) (Suppl. Fig. 5a ). On the other hand, individual variables and five interaction terms (callers*coverage, callers*percent GC, caller*machine model, callers*GIV(G>T/C>A), and callers*non-duplicated reads) were significant for O_Score variance in WES runs (Suppl. Fig. 5b ).
As all twelve WGS runs were done with TruSeq PCR-free libraries with the same amount of DNA input, the percentage of non-duplicated reads did not affect reproducibility. While individual variables may influence WES run reproducibility, their effect levels were dependent on caller selection ( Fig. 2d) . Taken together, only a few factors (read coverage and callers) affected WGS reproducibility, whereas several factors, such as caller, read coverage, insert fragment size, GC content, GIV (G>T/C>A) score, and their interactions influenced WES run reproducibility. It is noteworthy that since an older machine model (HiSeq1500) was used in only one WES sequencing center, which also had low insert fragment size and high GIV (G>T/C>A) scores in sequencing reads, the impact of machine model on the WES run reproducibility could be a confounding factor. In contrast, the most influential factor for the performance of WGS was the caller, next followed by read coverage.
Effect of non-analytical and analytical factors on mutation calling
To thoroughly investigate the influence of non-analytical and analytical factors on cancer mutation calling, we set out to define the truth set of somatic mutation in HCC1395 for our benchmarking study (see our "reference samples" manuscript, DOI:10.1101/625624).
With three different library preparation protocols and varying DNA input amounts across multiple library preparations, we analyzed outcomes using combinations of the three callers and three aligners. MuTect2 was reliable, except for calling of the 1 ng TruSeq-Nano libraries ( Fig. 3a) . Strelka2's performance suffered by more than 50% from the 1 ng TruSeq-Nano libraries, as did SomaticSniper. We conclude that Nextera Flex library preparation might be a better option for a low input DNA quantity. FFPE processing can have an effect on variant calling results 31 . In our study, samples of fresh cells and cells processed with FFPE were called with Strelka2, SomaticSniper, and MuTect2.
Both MuTect2 and Strelka2's precision and recall were greatly reduced when samples were subjected to FFPE processing (Fig. 3b) . On the other hand, SomaticSniper demonstrated only a small decrease in both metrics, but otherwise underperformed significantly compared with the other two callers.
Sometimes FFPE or low tumor purity samples are all that is available for study. Bioinformatics can potentially reduce sample related biases. To evaluate bioinformatics pipelines, reads were pre-processed using Trimmomatic 32 or BFC 33 to assess whether read trimming and error correction could affect WES variant call recall or precision (see Online Methods). Applying error correction with BFC to FFPE samples increased precision but did not improve the recall rate (Suppl. Fig. 6a ). However, precision was improved for fresh DNA samples that have undergone BFC processing, but with a lower recall rate than results from Trimmomatic processing. Taken together, these results indicate that BFC is appropriate in cases of severe DNA damage but may not be worthwhile if there is only mild damage from a process such as sonication.
FFPE is known to cause G>T/C>A artifacts as well 31 . Trimmomatic and BFC were investigated for their ability to detect these errors. Since the DNA damage causing the G>T/C>A mutation may not be isolated to only low quality base calls at the end of reads, Trimmomatic is not designed to remove this type of artifact. Trimmomatic processed data was more skewed toward C>A artifacts than was BFC processed data, which showed changes more broadly across nucleotide transitions (Fig. 4a) . BFC reduced C>A artifacts, but introduced a few artifacts of other types, such as T>C mutations, indicating that caution should be exercised when using bioinformatics tools to correct FFPE artifacts.
Calling accuracy was dependent on the choice of caller and aligner, as well as how the caller and aligner interact. Strelka2 results with BWA-aligned reads were balanced, whereas results with Bowtie2-aligned reads seemed conservative. In contrast, Strelka2 results with NovoAlignaligned reads seemed aggressive (Fig. 4b) . When we examined the mapping quality scores for the three alignments, BWA's mapping quality scores were usually between 50 and 60, Bowtie2's scores were between 40 and 50, and NovoAlign's scores were between 60 and 70.
Strelka2 was trained and modeled on the BWA alignment and thus works best in the bioinformatics context where it was developed 27 . Taken together, these results indicate that there might be a joint effect between aligner and caller, depending on how callers were developed and on which aligners' dataset they were trained on.
Next, the effect of the Genome Analysis Toolkit (GATK) local indel realignment and base quality score recalibration (BQSR) was queried. MuTect2 and Strelka2 identified a very similar number of SNVs regardless of whether the process was employed (Fig. 4c) . Conversely, SomaticSniper was highly sensitive to post alignment processing, with some SNVs gained and far more lost.
Relatedly, the precision and recall rate changed dramatically when this process was applied for SomaticSniper calling, but not for calling by MuTect2 or Strelka2 (Suppl. Fig. 6b, c) . Clearly, our study confirms, with real-world experimental data, the importance of a full understanding of how the various components of mutation analysis by NGS methods work and interact with each other.
Tumor purity and coverage also play a role in caller performance. As expected, higher read coverage yielded more SNV calls (Fig. 4d) . When tumor purity was high (>50%), 50X performed very similarly to 100X coverage across all callers tested. When tumor purity was low (<50%), calling was much more sensitive to sequencing depth. To test the performance of callers on low tumor purity samples, we pooled reads from WGS triplicate runs on samples that were sequenced at 100X coverage to generate coverage of either 200X or 300X on each cell line. In addition to the three main callers used in this study, we also included two new tools, TNscope 34 and Lancet 35 , to compare their capabilities for detecting mutations from a mix with tumor DNA as low as 5%. With high tumor purity (>50%), we again observed that the accuracy of all the callers, with the exception of SomaticSniper, declined slightly with higher read coverage, indicating that our truth set lacked <5% variant allele frequency (VAF) mutations. However, when tumor purity was 20% or lower, the benefit of higher coverage for mutation detection was apparent. For a sample with 20% tumor, Lancet, Strelka2, and TNscope performed similarly well with 300X coverage (Fig. 4d) . On the other hand, SomaticSniper performed poorly at any tumor purity level, and increased read coverage did not rescue performance. These results indicate that tumor purity is much more influential than coverage in the ranges tested here.
Performance of WGS and WES across multiple sequencing centers
As this study leveraged six sequencing centers performing twelve WES and WGS experiments simultaneously, we were able to assess inter-and intra-center reproducibility of the two sequencing platforms. Using our established call set as a reference, we defined resulting SNV calls from any of the NGS runs with the pair of cell lines into three categories: 1) Repeatable (SNVs in the truth set defined in "HighConf" and "MedConf" categories); 2) Gray zone (SNVs defined in "LowConf" and "Unclassified" categories); and 3) Non-Repeatable (SNVs not found in the truth set) (Suppl. Fig. 7) . Cross-center and cross-platform variations were very small for "Repeatable" SNVs, indicating that all individual NGS runs, regardless of sequencing centers or NGS platforms, detected most "true" mutations consistently. This "consistency" dropped dramatically for SNVs in the "Gray zone", and further down to nearly zero, if SNVs were "Non-Repeatable" ( Table 1) .
Taken together, these results indicated that there were two major sources for discordant SNV calls between any two different library preparations: 1) stochastic effects of sequence coverage on SNVs with low VAF, which are sensitive to read coverage and mainly represented by SNVs in the "Gray zone" group; 2) artifacts due to library preparation, mainly represented by SNVs in the "Non-Repeatable" group. The benefit of high read coverage not only empowers the detection of mutations with low VAF, but also increases result reproducibility (for both WES and WGS), likely due to reduction of stochastic effects.
Using multi-variate analysis, we were able to further dissect the source of variations driving reproducibility of mutation detection by WES and WGS. Consistent with our results from O_Score analysis (Fig. 2d) , callers, read coverage, and platforms were the major factors influencing the reproducibility of mutation detection. However, the subset of SNVs/indels (Repeatable, Non-Repeatable, and Gray zone) was the dominant source of inconsistent mutation calls (Suppl. Fig. 8 a) . In addition, we observed that the difference between inter-/intra-center variations was subjected to callers (Suppl. Fig. 8b ) and SNV/indels subsets (Suppl. Fig. 8c) . Overall, inter-center variations for WES were larger than inter-center variations for WGS, whereas the difference of intra-center variation between WES and WGS was observed to be insignificant (Suppl. Fig. 8d) .
Moreover, results from the Jaccard index score analysis confirmed our conclusions: for WES, Strelka2 was less reproducible than MuTect2 (Fig. 2b, Suppl. Fig. 4a, and Suppl. Fig. 6a ). As shown in Fig. 4a , Strelka2 was very sensitive in detecting C->A mutation artifacts from excessive sonication. Thus, it was not surprising to see that many "Non-Repeatable" SNVs detected by Strelka2 in WES were C->A mutations. At a less extensive level, MuTect2 also detected C->A mutation artifacts; however, this artifact was not observed by SomaticSniper (Suppl. Fig. 9 ).
Precision and recall rates from WES and WGS were also compared across all three callers and all twelve replicates directly. Mutations shared by two replicates generally had higher precision.
Moreover, almost all mutations called by both MuTect2 and SomaticSniper were true.
Leveraging additional callers increased precision; however, this was at the cost of recall (Fig. 5) .
Taken together, by the precision metric, WGS clearly out-performed WES across replicates, callers, and sequencing centers. These results demonstrate the importance of using enough library replicates during study design, rather than trying to compensate by using multiple callers.
Finally, we compared precision, recall, and F-score (as defined in Supplemental Methods) across a range of variant allele frequencies with three callers in both WES and WGS. Interestingly, Strelka2 exhibited the best performance on WGS samples but the worst performance on WES samples (Suppl. Fig. 10) , which was consistent with the results from the reproducibility study ( Fig. 2) . On the other hand, even though SomaticSniper did not perform well overall, it was not affected by C>A artifacts. However, for both WES and WGS runs, we did observe that the limit of VAF calling by SomaticSniper was ~12%, and many false positives were misidentified by SomaticSniper at a higher VAF (Suppl. Fig. 11a, b) . Therefore, the "better" performance of SomaticSniper compared to Strelka2 on WES was driven by SomaticSniper's insensitivity to artifacts from the DNA fragmentation process (Fig. 1c and Suppl. Fig. 11a ).
Discussion
We observed that each component of the sequencing and analysis process can affect the final outcome. Overall concordance and correlation of WES and WGS results were good. WES had a better coverage/cost ratio than WGS. However, sequencing coverage of the WES target regions was not even (Suppl. Fig. 11c ). In addition, WES showed more batch effects/artifacts due to laboratory processing and thus had larger variation between runs, laboratories, and likely between researchers preparing the libraries. As a result, WES was less reproducible than WGS.
WGS had more uniform coverage and was less sensitive to different runs and laboratories. Our experimental design also allowed us to estimate inter-/intra-center variation for both WES and WGS platforms. WES had much larger inter-center variation than WGS; however, intra-center variation for both platforms was quite comparable (Suppl. Fig. 8 ). Biological (library) repeats removed some artifacts due to random events ("Non-Repeatable" calls) and thus offered much better calling precision than did a single test. Analytical repeats (two bioinformatics pipelines) also increased calling precision at the cost of increased false negatives (Fig. 5) . We found that biological replicates are more important than bioinformatics replicates in cases where high specificity and sensitivity are needed.
Detection of cancer mutations is an integrated process. No individual component can be singled out in isolation as more important than any other, and specific components affect and interact with each other. Every component and every combination of components can lead to false discovery (false positives or false negatives). Individual components of cancer mutation calling should never be considered "plug and play". Although the initial steps of NGS test validation may be performed in three separate stages (platform, test-specific, and informatics) 36 , our study demonstrates the complex interdependency of these stages on overall NGS test performance. Thus, final validation and verification studies should be performed using the entire sample-to-result pipeline. Detailed recommendations of cancer mutation detection experiments and analysis are provided in Suppl. Table 6 .
We cannot conclude that results from our study are generalizable to other cancer types.
However, high complexity of chromosome loss/gains (see our "reference samples" manuscript, DOI:10.1101/625624) and a large number of somatic mutations, cell line HCC1395 resembles the abnormalities commonly seen in a hyper-diploid cancer genome.
In summary, the pair of tumor/normal cell lines, data sets with FFPE DNA, tumor/normal DNA mix, and performance of bioinformatics components established in this study may serve as a reference for the NGS research community to perform benchmarking studies for the development of new NGS products, assays, and informatics tools. We also provide recommendations for DNA fragmentation for WES runs, and a selection of NGS platforms, and bioinformatics tools based on the nature of available biosamples and study objectives.
Online Methods
Data availability
All raw data (FASTQ files) are available on NCBI's SRA database (SRP162370). The truth set for somatic mutations in HCC1395, VCF files derived from individual WES and WGS runs, and source codes for "tornado" plot are available on NCBI's ftp site (ftp://ftptrace.ncbi.nlm.nih.gov/seqc/ftp/release/Somatic_Mutation_WG/). Alignment files (BAM) are also available on Seven Bridges' s Cancer Genomics Cloud (CGC) platform and Digicon's BioGenLink™.
NIH Biowulf cluster (http://hpc.nih.gov). Original data was also backed up on the servers provided by Center for Biomedical Informatics and Information Technology (CBIIT), NCI.
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